ACTA1 and systemic sclerosis: Although the possible role of the CD248 molecule in SSc pathogenesis is largely unknown, it has been reported that this molecule is involved in the fibroproliferative process by modulating the PDGF-BB pathway [21] and collaborating with the TGF-β pathway to induce α-SMA expression [48].